Herrad Baurmann

Bergisch Gladbach, NW, Germany

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications

Distinct HLA Haplotypes Are Associated With an Altered Strength of SARS-CoV-2-Specific T-Cell Responses and Unfavorable Disease Courses.

Distinct HLA Haplotypes Are Associated With an Altered Strength of SARS-CoV-2-Specific T-Cell Responses and Unfavorable Disease Courses.

Journal: European journal of immunology
Published: September 03, 2024

CSF1R+ myeloid-monocytic cells drive CAR-T cell resistance in aggressive B cell lymphoma.

CSF1R+ myeloid-monocytic cells drive CAR-T cell resistance in aggressive B cell lymphoma.

Journal: Cancer cell
Published: August 25, 2024

Machine learning analysis of humoral and cellular responses to SARS-CoV-2 infection in young adults.

Machine learning analysis of humoral and cellular responses to SARS-CoV-2 infection in young adults.

Journal: Frontiers in immunology
Published: February 04, 2023

Vaccines against the original strain of SARS-CoV-2 provide T cell memory to the B.1.1.529 variant.

Vaccines against the original strain of SARS-CoV-2 provide T cell memory to the B.1.1.529 variant.

Journal: Communications medicine
Published: March 14, 2022

Rapid Manufacturing of Highly Cytotoxic Clinical-Grade SARS-CoV-2-specific T Cell Products Covering SARS-CoV-2 and Its Variants for Adoptive T Cell Therapy.

Rapid Manufacturing of Highly Cytotoxic Clinical-Grade SARS-CoV-2-specific T Cell Products Covering SARS-CoV-2 and Its Variants for Adoptive T Cell Therapy.

Journal: Frontiers in bioengineering and biotechnology
Published: January 31, 2022

A multicenter prospective, randomized, placebo-controlled phase II/III trial for preemptive acute graft-versus-host disease therapy.

A multicenter prospective, randomized, placebo-controlled phase II/III trial for preemptive acute graft-versus-host disease therapy.

Journal: Leukemia
Published: June 17, 2020

Does rehabilitation pose a risk to patients suffering from haemato-oncological diseases? Results of a monocentric, retrospective analysis in Germany.

Does rehabilitation pose a risk to patients suffering from haemato-oncological diseases? Results of a monocentric, retrospective analysis in Germany.

Journal: European journal of cancer care
Published: November 09, 2017

Imatinib in myeloid/lymphoid neoplasms with eosinophilia and rearrangement of PDGFRB in chronic or blast phase.

Imatinib in myeloid/lymphoid neoplasms with eosinophilia and rearrangement of PDGFRB in chronic or blast phase.

Journal: Annals of hematology
Published: June 04, 2017

Allogeneic hematopoietic cell transplantation as curative therapy for non-transformed follicular lymphomas.

Allogeneic hematopoietic cell transplantation as curative therapy for non-transformed follicular lymphomas.

Journal: Bone marrow transplantation
Published: May 12, 2015

Long-term results of adjuvant donor lymphocyte transfusion in AML after allogeneic stem cell transplantation.

Long-term results of adjuvant donor lymphocyte transfusion in AML after allogeneic stem cell transplantation.

Journal: Bone marrow transplantation
Published: April 10, 2015

Long-term outcome of patients with newly diagnosed chronic myeloid leukemia: a randomized comparison of stem cell transplantation with drug treatment.

Long-term outcome of patients with newly diagnosed chronic myeloid leukemia: a randomized comparison of stem cell transplantation with drug treatment.

Journal: Leukemia
Published: March 25, 2015

Hematopoietic stem-cell transplantation for advanced systemic mastocytosis.

Hematopoietic stem-cell transplantation for advanced systemic mastocytosis.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: August 27, 2014
Showing 1-12 of 17

Last Updated: 09/26/2026